| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/17425247.2011.566267 |
| P698 | PubMed publication ID | 21417782 |
| P50 | author | Gelin Xu | Q37608134 |
| P2093 | author name string | Xinfeng Liu | |
| Yongjun Jiang | |||
| Juehua Zhu | |||
| P2860 | cites work | The blood-brain barrier: bottleneck in brain drug development | Q22336985 |
| Evaluation of Bone Marrow- and Brain-Derived Neural Stem Cells in Therapy of Central Nervous System Autoimmunity | Q24598521 | ||
| Human neural stem cells genetically modified to overexpress brain‐derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model | Q39659177 | ||
| Transplanted neural precursors enhance host brain-derived myelin regeneration | Q39762323 | ||
| Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury | Q40244557 | ||
| Intraarterial autologous implantation of adult stem cells for patients with Parkinson disease | Q42469445 | ||
| Preparation and evaluation of fexofenadine microemulsions for intranasal delivery | Q42968635 | ||
| Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats | Q43239771 | ||
| Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity | Q43991286 | ||
| Visualization of in vivo olfactory uptake and transfer using fluorescein dextran | Q44223179 | ||
| Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy | Q45863679 | ||
| Combination therapy with intranasal NGF and electroacupuncture enhanced cell proliferation and survival in rats after stroke | Q46211036 | ||
| Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype | Q46553973 | ||
| Brain uptake of an anti-ischemic agent by nasal administration of microparticles | Q46733301 | ||
| Intranasal insulin improves cognition and modulates beta-amyloid in early AD. | Q46945303 | ||
| Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration | Q48094330 | ||
| Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. | Q48122882 | ||
| Blood vessels form a scaffold for neuroblast migration in the adult olfactory bulb. | Q48151551 | ||
| Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage | Q48821396 | ||
| Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis | Q48864656 | ||
| Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system | Q48869715 | ||
| Experimental pneumococcal meningitis in mice: a model of intranasal infection | Q48960928 | ||
| Chain migration of neuronal precursors. | Q49115425 | ||
| Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease | Q50527409 | ||
| Lineage-negative bone marrow cells travel bidirectionally in the olfactory migratory stream but maintain hematopoietic phenotype | Q50791722 | ||
| Videos in clinical medicine. Lumbar puncture | Q51127144 | ||
| Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. | Q54404265 | ||
| Intranasal Clobazam Delivery in the Treatment of Status Epilepticus | Q57343262 | ||
| Executive Summary: Heart Disease and Stroke Statistics—2010 Update | Q57413935 | ||
| Direct conversion of fibroblasts to functional neurons by defined factors | Q24641912 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Update of the stroke therapy academic industry roundtable preclinical recommendations | Q29615508 | ||
| The blood-brain barrier in health and chronic neurodegenerative disorders | Q29616411 | ||
| Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia | Q33322707 | ||
| Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. | Q33367115 | ||
| Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats | Q33699018 | ||
| In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XL | Q33744707 | ||
| Subacute neural stem cell therapy for traumatic brain injury | Q33870587 | ||
| Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice | Q33928463 | ||
| Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an NFkappaB-mediated increase in interleukin-6 production | Q33938085 | ||
| Intranasal delivery of cells to the brain. | Q34016739 | ||
| Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. | Q34019665 | ||
| Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients | Q34023024 | ||
| Filamentous phage as vector-mediated antibody delivery to the brain | Q34026070 | ||
| Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain | Q34287449 | ||
| Intranasal insulin improves memory in humans | Q34337964 | ||
| Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study | Q34934840 | ||
| Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders | Q35011791 | ||
| Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells | Q35848288 | ||
| Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia | Q36797965 | ||
| Intranasal insulin to improve memory function in humans | Q36887499 | ||
| Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. | Q36954944 | ||
| New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163 | Q37036896 | ||
| Molecular probes: insights into design and analysis from computational and physical chemistry. | Q37061477 | ||
| Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. | Q37273874 | ||
| The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain | Q37313963 | ||
| Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice | Q37596491 | ||
| Intranasal delivery to the central nervous system: mechanisms and experimental considerations | Q37624592 | ||
| Progress and prospects: stem cells and neurological diseases | Q37794781 | ||
| Intranasally delivered TGF-beta1 enters brain and regulates gene expressions of its receptors in rats | Q38298924 | ||
| A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke | Q38485063 | ||
| Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. | Q39311874 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 623-632 | |
| P577 | publication date | 2011-03-19 | |
| P1433 | published in | Expert Opinion on Drug Delivery | Q5421203 |
| P1476 | title | Intranasal delivery of stem cells to the brain | |
| P478 | volume | 8 |
| Q34540968 | Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice |
| Q36112863 | CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery. |
| Q27025754 | Cell based therapies for ischemic stroke: from basic science to bedside |
| Q38140071 | Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end? |
| Q37957961 | Clinical trials of intranasal delivery for treating neurological disorders--a critical review |
| Q39261169 | Cultivation of RPMI 2650 cells as an in-vitro model for human transmucosal nasal drug absorption studies: optimization of selected culture conditions |
| Q64276142 | Deciduous DPSCs Ameliorate MPTP-Mediated Neurotoxicity, Sensorimotor Coordination and Olfactory Function in Parkinsonian Mice |
| Q34339313 | Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting |
| Q39128950 | Drug delivery in overcoming the blood-brain barrier: role of nasal mucosal grafting |
| Q33597885 | Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease |
| Q33783563 | Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents |
| Q40269191 | Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery |
| Q92698378 | Intracerebroventricular Administration of Neural Stem Cells after Cardiac Arrest |
| Q90216638 | Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson's Disease |
| Q87716594 | Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis |
| Q48346065 | Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats |
| Q53608103 | Intranasal delivery of central nervous system-retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis. |
| Q38342080 | Intranasal delivery of stem cells as therapy for central nervous system disease |
| Q38553213 | Intranasal delivery: circumventing the iron curtain to treat neurological disorders |
| Q37142166 | Intranasal treatment of central nervous system dysfunction in humans |
| Q59000021 | MicroRNA: Not Far from Clinical Application in Ischemic Stroke |
| Q26830211 | Neurological disorders and the potential role for stem cells as a therapy |
| Q91765663 | Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy |
| Q38353261 | Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke. |
| Q98177558 | Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis |
| Q28072442 | Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases |
| Q38172567 | Roadmap of miR-122-related clinical application from bench to bedside |
| Q55610792 | The Route by Which Intranasally Delivered Stem Cells Enter the Central Nervous System. |
| Q54518671 | The paradox role of regulatory T cells in ischemic stroke. |
| Q55417928 | Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives. |
Search more.